Drug firm Wockhardt reports narrowing of Q4 net loss to Rs 14.47 cr

Drug firm Wockhardt Monday reported narrowing of a consolidated net loss of Rs 14.47 crore for the quarter ended March 2019. The company had posted a net loss of Rs 154.55 crore for the corresponding period of the previous fiscal, Wockhardt said in a filing to the BSE.

Consolidated revenue from operations of the company stood at Rs 979.13 crore for the quarter under consideration. It was Rs 1,018.26 crore for the corresponding period a year ago. For the fiscal year ended March this year, its net loss stood at Rs 194.53 crore as against Rs 608.30 crore for the previous fiscal year. Consolidated revenue from operations for the recently concluded fiscal year stood at Rs 4,158.38 crore. It was Rs 3,936.90 crore for the previous year. Shares of Wockhardt closed at Rs 408.65 per scrip on the BSE, up 0.41 percent from its previous close.